HCAT Health Catalyst Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HCAT

Price (delayed)

$1.94

Market cap

$143.35M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.74

Enterprise value

$254.07M

?
Relative Growth: Rel. Growth: 8
Relative Strength: Rel. Strength: 4
Relative Valuation: Rel. Valuation: 38
Relative Profitability: Rel. Profitability: 11

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage ...

Highlights
Health Catalyst's gross margin has increased by 10% YoY and by 2.5% from the previous quarter
The company's gross profit rose by 7% YoY
The net income has contracted by 49% from the previous quarter
HCAT's EPS is down by 47% since the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://www.healthcatalyst.com
Peers: PHR PHUN

Key stats

What are the main financial stats of HCAT

HCAT stock price

How has the Health Catalyst stock price performed over time
Intraday
45.86%
1 week
38.57%
1 month
23.57%
1 year
-50.89%
YTD
-18.83%
QTD
52.76%

Financial performance

How have Health Catalyst's revenue and profit performed over time
Revenue
$302.48M
Gross profit
$150.9M
Operating income
-$247.16M
Net income
-$265.26M
Gross margin
49.9%
Net margin
-87.7%
The operating margin has shrunk by 58% QoQ
The operating income has dropped by 54% since the previous quarter
The company's net margin has shrunk by 53% QoQ
The net income has contracted by 49% from the previous quarter

Price vs fundamentals

How does HCAT's price correlate with its fundamentals

Growth

What is Health Catalyst's growth rate over time

Valuation

What is Health Catalyst stock price valuation
P/E
N/A
P/B
1.03
P/S
0.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.84
HCAT's EPS is down by 47% since the previous quarter
HCAT's price to book (P/B) is 61% lower than its 5-year quarterly average of 1.8
The company's equity fell by 44% QoQ and by 44% YoY
The stock's price to sales (P/S) is 89% less than its 5-year quarterly average of 3.0 and 47% less than its last 4 quarters average of 0.6
The company's revenue fell by 2.8% YoY and by 2.8% QoQ

Efficiency

How efficient is Health Catalyst business performance
HCAT's return on equity has dropped by 64% since the previous quarter
HCAT's ROS has dropped by 58% since the previous quarter
The ROIC has plunged by 56% from the previous quarter
Health Catalyst's return on assets has shrunk by 56% QoQ

Dividends

What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HCAT.

Financial health

How did Health Catalyst financials performed over time
HCAT's total assets is 50% greater than its total liabilities
HCAT's total assets is down by 18% since the previous quarter and by 18% year-on-year
The current ratio has contracted by 11% from the previous quarter and by 11% YoY
The company's debt is 23% higher than its equity
The debt to equity has soared by 76% since the previous quarter and by 76% year-on-year
The company's equity fell by 44% QoQ and by 44% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.